Edition:
United Kingdom

Tocagen Inc (TOCA.OQ)

TOCA.OQ on NASDAQ Stock Exchange Global Select Market

13.99USD
7:26pm GMT
Change (% chg)

$1.16 (+9.04%)
Prev Close
$12.83
Open
$12.79
Day's High
$13.99
Day's Low
$12.73
Volume
30,626
Avg. Vol
62,283
52-wk High
$17.75
52-wk Low
$8.64

Select another date:

Mon, Jan 8 2018

BRIEF-Tocagen Estimates Cash, Cash Equivalents And Marketable Securities About $89.0 Million As Of Dec 31, 2017

* TOCAGEN SAYS ESTIMATE CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES WERE ABOUT $89.0 MILLION AS OF DEC 31, 2017 - SEC FILING

BRIEF-Tocagen Q3 loss per share $0.50

* Tocagen reports third quarter 2017 financial and business results

BRIEF-Tocagen to accelerate Toca 511 & Toca FC development into Phase 3 trial

* Tocagen to accelerate Toca 511 & Toca FC development into pivotal Phase 3 trial Source text for Eikon: Further company coverage:

BRIEF-Tocagen Q2 loss per share $0.56

* Tocagen reports second quarter 2017 financial and business results

BRIEF-Tocagen reports quarterly loss per share $0.56‍​

* Qtrly license revenue $10,000 versus $13,000 Source text: (http://bit.ly/2wuNluv) Further company coverage:

BRIEF-Tocagen receives PRIME designation for Toca 511

* Tocagen receives European Medicines Agency Priority Medicines (PRIME) designation for Toca 511 in high grade Glioma Source text for Eikon: Further company coverage:

Select another date: